Cost of GLP-1 Receptor Agonists The high cost of GLP-1 RAs represents a barrier to widespread adoption
For mediation analysis, the product of coefficients method assumes a linear relationship between GLP-1Ras and SA, but in reality, the relationship may be more complex
the breakdown of cartilage causes bones in the joint to rub together, resulting in severe pain
This points to a possible efficacy advantage compared to Rezdiffra
References View all 6 references + Pickart, L., & Thaler, M
Divergence across payer type matters: Commercial patients adopt GLP1s earlier and often remain on monotherapy, while Medicare patients face stricter controls and higher comorbidity burdens